ARCHIVES

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

December 9, 2005

CCOP Recompetition Approved, “Institutionalized;” Board Okays Concept For Eight Minority CCOPs

February 3, 1989

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013